ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.25, sa.11, ss.821-828, 2021 (SCI-Expanded)
Objective: Doxorubicin (DOX) is a well-known cardiotoxic agent, whereas sacubitril/valsartan (Sac/Val) is an effective treatment option in heart failure. In this study, we aimed to evaluate the effect of Sac/Val on DOX-induced cardiotoxicity in pretreatment mice model.